RJA
CVRS

Raymond James & Associates’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Raymond James & Associates’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-34,137
Closed -$59K – 3809
2019
Q1 		$59K Hold
34,137
– – ﹤0.01% 3463
2018
Q4 		$29K Hold
34,137
– – ﹤0.01% 3421
2018
Q3 		$48K Buy
+34,137
New +$37.4K ﹤0.01% 3496

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Raymond James & Associates's CVRS Position: Q2 2019 in Review

Raymond James & Associates sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2019, closing a stake of 34,137 shares — an estimated $59K sold.

Raymond James & Associates first reported a position in CVRS in Q3 2018 and held it in 3 quarters. The position peaked at $59K in Q1 2019. 81 funds tracked by Wall St. Rank hold CVRS as of Q2 2019.

  • Raymond James & Associates reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2019 after selling out during the quarter.
  • Raymond James & Associates sold 34,137 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2019, an estimated $59K.
  • Raymond James & Associates first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q3 2018 and held it in 3 quarters.
  • Raymond James & Associates's CORINDUS VASCULAR ROBOTICS, INC position peaked at $59K in Q1 2019.
  • 81 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2019.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.